Provider review
Kova review
Prints the renewal rate on the same card as the introductory one.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$299/mo month-to-month after a $249 first month
Visit KovaWhich reveals that the true month-to-month rate is more than double the twelve-month rung.
Price as published
Kova
$299/mo month-to-month after a $249 first month
- Vs median
- $124/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded, 503A or 503B pharmacies, not named
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The commitment ladder here runs the usual way and is unusually honest about its top rung. Most sellers publish an introductory monthly figure and let the renewal arrive on its own; Kova prints both on the same card, so you know before starting that the first month is a discount and exactly what the price becomes afterwards. That one sentence is worth more than a lower headline would be. What it reveals is a steep structure. The true month-to-month rate is more than double the twelve-month rung, which makes this one of the widest commit-or-not gaps here, and staying flexible is what you pay for. If your plan is to start low and watch how you respond before deciding anything, that top figure is the number that applies to you, and it is the one this page is honest enough to print rather than bury. Payment can be spread or made in full, both pharmacy classes get a mention, and no milligram appears against any rung.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the renewal rate stated before you pay the first month
- You have already decided to commit for six or twelve months
- You want the option to pay in full or spread the cost
Look elsewhere if
- You want to stay month-to-month — that rate is more than double the annual one
- You want the advertised figure to be the ongoing one
- You want a dose behind the number
What it actually costs
Price as published
$299/mo month-to-month after a $249 first month
- Vs median
- $124/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. The renewal rate is printed on the same card as the introductory one, so the step up is known before starting rather than met at the second charge — almost no other seller here does that. What it reveals is a steep structure: the true month-to-month rate is more than double the twelve-month rate, one of the widest commit-or-not gaps here, and staying flexible is what costs.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Prints the renewal rate on the same card as the introductory one.
- The full ladder is published, from one month to twelve.
- Payment can be spread monthly or made in full, stated as a choice.
Pharmacy, labs and oversight
Kova says it uses 503A or 503B pharmacies, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Kova publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedSays it uses 503A or 503B pharmacies, but does not say which one.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The commitment ladder here runs the usual way and is unusually honest about its top rung. Most sellers publish an introductory monthly figure and leave the renewal to arrive on its own; Kova prints both on the same card, so a reader knows before starting that the first month is a discount and what the price becomes afterwards. That single sentence is worth more than a lower headline. What it reveals is a steep structure. The true month-to-month rate is more than double the twelve-month rung, which makes this one of the widest commit-or-not gaps on the page, and a reader who wants to stay flexible pays heavily for it. For anyone starting low and watching how they respond, that is the relevant number, and it is the one the page is honest enough to print. Payment can be spread or made in full; both pharmacy classes get a mention; no milligram appears against any rung.
The honest cons
The true month-to-month rate is more than double the twelve-month rung.
- The advertised one-month figure is an introductory rate that steps up.
- No milligram appears against any rung.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Kova is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Kova does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#348 of 548
Ordered with the companies that pay us first, and Kova is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.